Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Maria Carolina Sanabria-Salas"'
Autor:
Maria Carolina Sanabria-Salas, Nina Anggala, Brittany Gillies, Helia Purnaghshband, Kirsten Farncombe, Larissa Peck, Laura Redondo, Peter Sabatini, Renee Hofstedter, Philippe Bedard, Raymond Kim
Publikováno v:
Genetics in Medicine Open, Vol 2, Iss , Pp 100966- (2024)
Externí odkaz:
https://doaj.org/article/ee3f1bba532149a7ad5a9b50d3b0346c
Autor:
Larissa Peck, Maria Carolina Sanabria-Salas, Sarah Ridd, Helia Purnaghshband, Wes Morrison, C. Anne Koch, Raymond Kim
Publikováno v:
Genetics in Medicine Open, Vol 2, Iss , Pp 101447- (2024)
Externí odkaz:
https://doaj.org/article/e0f98cab98be412f99806f09909d705c
Autor:
Lina Maria Bejarano-Rivera, Mayra Alejandra Ramírez-Díaz, Laura Rey-Vargas, Juan Carlos Mejía Henao, Maria Carolina Sanabria-Salas, Silvia Juliana Serrano-Gómez
Publikováno v:
Revista Colombiana de Cancerología. 27:80-90
Objetivo. Analizar las diferencias en la presentación de variables clínico-patológicas, de acuerdo con la expresión proteica de GRB7, en tumores HER2 positivos en mujeres colombianas con cáncer de mama invasivo, diagnosticado entre los años 201
Autor:
Maria Carolina Sanabria Salas, Ana María Pedroza Duran, Ana Lucía Rivera, Daniel Gonzalez Hurtado, Daniela María Cuadrado Franco, María Andrea Quintero Ortiz, Raúl Alexis Suarez Rodriguez, Ana Milena Gómez Camacho, María Carolina Manotas, Ricardo Brugés Maya, Luis Hernán Guzmán Abi-Saab, Ximena Briceño Morales, Jesús Oswaldo Sánchez Castillo, Fernando Contreras Mejía, Carlos Lehmann Mosquera, Mauricio García-Mora, Javier Ángel Aristizabal, Iván Fernando Mariño Lozano, Eduardo Alfonso Rojas Andrade, Sandra Esperanza Diaz Casas
Publikováno v:
Revista Colombiana de Cancerología. 27:26-41
Introducción. Los síndromes de cáncer de mama hereditario (SCMH) corresponden a un 5% a 10% de todos los casos de la enfermedad, en su mayoría explicados por mutaciones en los genes BRCA1 y BRCA2. Se han publicado múltiples guías y recomendacio
Publikováno v:
Molecular Genetics & Genomic Medicine. 11
Autor:
Laura Rey Vargas, Lina Maria Bejarano, Juan Carlos Mejia Henao, Diego Felipe Ballen Lozano, Maria Carolina Sanabria Salas, Silvia Juliana Serrano Gomez
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 32:C015-C015
Introduction: HER2-low expression tumors, either with weak or incomplete membrane expression (immunohistochemistry (IHC) 1+ or 2+ with negative in situ hybridization (ISH) result), are considered and treated as HER2-negative tumors. However, recent c
Autor:
Silvia J. Serrano-Gómez, Laura Rey-Vargas, Lina Bejarano, Juan Carlos Mejía-Henao, Maria Carolina Sanabria-Salas
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 32:A072-A072
Introduction: Socioeconomic disadvantages can contribute to breast cancer health disparities among populations. However, it has been shown that other factors related to the etiology of breast cancer and the biology of the tumor, might also act as det
Autor:
Carlos A. Huertas-Caro, Mayra A. Ramírez, Laura Rey-Vargas, Lina María Bejarano-Rivera, Diego Felipe Ballen, Marcela Nuñez, Juan Carlos Mejía, Luz Fernanda Sua-Villegas, Alicia Cock-Rada, Jovanny Zabaleta, Laura Fejerman, María Carolina Sanabria-Salas, Silvia J. Serrano-Gomez
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract Triple negative breast cancer (TNBC) is highly immunogenic and high levels of tumor infiltrating lymphocytes (TILs) have been associated with a better prognosis and higher probability to achieve pathological complete response. Here, we explo
Externí odkaz:
https://doaj.org/article/4453755806eb4b11963e5145bea36bdc
Autor:
Laura Rey Vargas, Lina Maria Bejarano, Juan Carlos Mejia Henao, Luz Fernanda Sua Villegas, Jhon Faustino Bastidas Andrade, Carlos Andrés Ossa Gómez, Laura Fejerman, Maria Carolina Sanabria Salas, Silvia Juliana Serrano Gomez
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 31:PR-04
Introduction: Breast cancer is the most prevalent cancer in women worldwide. It is a heterogeneous disease that has been classified into intrinsic subtypes based on gene expression analyses. Previous studies have reported a higher proportion of HER2-
Autor:
Natalia L. Acosta-Vega, Rodolfo Varela, Jorge Andrés Mesa, Jone Garai, Alberto Gómez-Gutiérrez, Silvia J. Serrano-Gómez, Jovanny Zabaleta, María Carolina Sanabria-Salas, Alba L. Combita
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundAfrican ancestry is a known factor associated with the presentation and aggressiveness of prostate cancer (PC). Hispanic/Latino populations exhibit varying degrees of genetic admixture across Latin American countries, leading to diverse lev
Externí odkaz:
https://doaj.org/article/ac93b3caeb6a46279ba77085872f81cd